4 Result: AstraZeneca
FDA Grants Accelerated Approval to a New Breast Cancer Treatment
September 04th, 2026
Silver Spring, MD / CRWE PRESS RELEASE / September 04, 2026 - The U.S. Food and Drug Administration today expanded treatment options for adult patients with advanced breast cancer, reflecting the FDA’s commitment to advancing medical innov. Read more
Earnings Preview: Key Expectations for AstraZeneca, Nucor, Celestica
July 25th, 2026
LAS VEGAS, NV / CRWE PRESS RELEASE / July 25, 2026 - Several companies are expected to unveil their financial results on Monday, July 27, including: AstraZeneca PLC (NYSE: AZN), the global biopharmaceutical company known for its portfolio of oncol. Read more
AstraZeneca, AMSC, Lifecore Biomedical, Arbor Realty Trust: Biotech News, Bullish Perceptions
June 04th, 2023
AstraZeneca's (Nasdaq: AZN) announced that TAGRISSO (osimertinib) has demonstrated a significant improvement in overall survival (OS) in patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC).&nb. Read more
Q1 2023 Earnings Report: KE Holdings and Bath & Body Works Exceed Expectations, Sociedad Química y Minera de Chile Falls Short; Revvity Inks Licensing Deal with AstraZeneca
May 18th, 2023
KE Holdings Inc. (NYSE: BEKE) reported better-than-expected adjusted earnings per share (EPS) for the first quarter of 2023. The company's adjusted EPS stood at $0.43, surpassing the consensus estimate of $0.23. In pre-market trading, $BEKE . Read more
Want To Find Some News?
News By Industries
Recent Post
-
FDA Grants Accelerated Approval to a New Breast Cancer Treatment
September 04th, 2026Signing Day Is Not the End of Recruiting
September 04th, 2026Treasury, IRS Move to End Tax-Exempt Status for Discriminatory Practices in Private Schools
September 03rd, 2026FDA Approves First Drug to Treat Alexander Disease
September 03rd, 2026How Coaching Staffs Evaluate Athletes Across a Season
September 03rd, 2026
Member Login